BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11179115)

  • 21. Relationship between bronchial hyperreactivity and bronchodilation in patients with allergic rhinitis.
    Ciprandi G; Signori A; Cirillo I
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):460-6. PubMed ID: 21624744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary function parameters in patients with allergic rhinitis.
    Bavbek S; Saryal S; Karabiyikoglu G; Misirligil Z
    J Investig Allergol Clin Immunol; 2003; 13(4):252-8. PubMed ID: 14989114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low levels of fractional exhaled nitric oxide and deep inhalation bronchoprotection are associated with mannitol non-responsiveness in asthma.
    Davis BE; Stewart SL; Martin AL; Cockcroft DW
    Respir Med; 2014 Jun; 108(6):859-64. PubMed ID: 24702886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis.
    Prieto L; Gutiérrez V; Liñana J; Marín J
    Eur Respir J; 2001 Jan; 17(1):64-70. PubMed ID: 11307758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.
    Ciprandi G; Pistorio A; Tosca M; Ferraro MR; Cirillo I
    Respir Med; 2009 Feb; 103(2):289-95. PubMed ID: 18818065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection.
    Allen ND; Davis BE; Hurst TS; Cockcroft DW
    Chest; 2005 Dec; 128(6):4018-23. PubMed ID: 16354875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis.
    Prieto L; Gutiérrez V; Bertó JM; Tornero C; Camps B; Pérez MJ
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):273-9. PubMed ID: 7552931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchial hyperreactivity in patients with allergic rhinitis: forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor.
    Ciprandi G; Tosca MA; Signori A; Cirillo I
    Allergy Asthma Proc; 2011; 32(2):4-8. PubMed ID: 21439158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.
    Ciprandi G; Cirillo I; Vizzaccaro A; Monardo M; Tosca MA
    Respir Med; 2005 Dec; 99(12):1606-12. PubMed ID: 16291083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in residual volume during induced bronchoconstriction in healthy and asthmatic subjects.
    Pellegrino R; Violante B; Selleri R; Brusasco V
    Am J Respir Crit Care Med; 1994 Aug; 150(2):363-8. PubMed ID: 8049816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airway responsiveness to methacholine and risk of asthma in patients with allergic rhinitis.
    Prieto L; Bertó JM; Gutierrez V
    Ann Allergy; 1994 Jun; 72(6):534-9. PubMed ID: 8203797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchial hyperreactivity and spirometric impairment in patients with allergic rhinitis.
    Cirillo I; Vizzaccaro A; Tosca MA; Negrini S; Negrini AC; Marseglia G; Ciprandi G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):79-83. PubMed ID: 16128221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).
    De Meer G; Heederik D; Postma DS
    Am J Respir Crit Care Med; 2002 Feb; 165(3):327-31. PubMed ID: 11818315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways.
    Brown RH; Reynolds C; Brooker A; Talalay P; Fahey JW
    Respir Res; 2015 Sep; 16(1):106. PubMed ID: 26369337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of lung inflation in airway hyperresponsiveness and in asthma.
    Scichilone N; Togias A
    Curr Allergy Asthma Rep; 2004 Mar; 4(2):166-74. PubMed ID: 14769267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The severity of breathlessness during challenges with inhaled methacholine and hypertonic saline in atopic asthmatic subjects. The relationship with deep breath-induced bronchodilation.
    Sont JK; Booms P; Bel EH; Vandenbroucke JP; Sterk PJ
    Am J Respir Crit Care Med; 1995 Jul; 152(1):38-44. PubMed ID: 7599850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchial challenge, assessed with forced expiratory manoeuvres and airway impedance.
    Broeders ME; Molema J; Hop WC; Folgering HT
    Respir Med; 2005 Aug; 99(8):1046-52. PubMed ID: 15950147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchoconstriction-triggered cough is impaired in typical asthmatics.
    Ohkura N; Fujimura M; Tokuda A; Nakade Y; Nishitsuji M; Abo M; Katayama N
    J Asthma; 2010 Feb; 47(1):51-4. PubMed ID: 20100021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchial responsiveness, spirometry and mortality in a cohort of adults.
    Becker EC; Wölke G; Heinrich J
    J Asthma; 2013 May; 50(4):427-32. PubMed ID: 23343387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airway narrowing associated with inhibition of deep inspiration during methacholine inhalation in asthmatics.
    King GG; Moore BJ; Seow CY; Paré PD
    Am J Respir Crit Care Med; 2001 Jul; 164(2):216-8. PubMed ID: 11463590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.